Skip to main content

Table 1 Personal, demographic, and operative data

From: Myocardial protection with histidine-tryptophan-ketoglutarate solution in comparison with hypothermic hyperkalemic blood solution in the correction of acyanotic congenital heart diseases

 

Group

P

HTK

HHB

Mean

±SD

Median

IQR

Mean

±SD

Median

IQR

Age (months)

15.53

5.57

16.50

10.00

21.00

14.80

5.94

14.50

10.00

21.00

0.624*

Weight (kg)

7.69

0.84

7.85

7.20

8.30

7.70

1.07

7.95

7.20

8.60

0.988*

Surgery duration (min)

208.60

24.41

215.00

210.00

225.00

202.07

28.25

210.00

190.00

220.00

0.342

CPB time (minutes)

115.87

5.73

115.00

110.00

120.00

112.07

22.38

114.50

110.00

120.00

0.374

Ao clamp time (min)

84.83

4.19

85.00

83.00

88.00

78.93

18.74

82.00

75.00

87.00

0.102

 

Number

%

Number

%

P

Sex

Male

18

60.0%

14

46.7%

0.301**

Female

12

40.0%

16

53.3%

Operation

Atrial septal defect

8

26.7%

7

23.3%

0.648

Ventricular septal defect

9

30%

10

33.3%

Atrioventricular septal defect

10

33.3%

7

23.3%

Partial anomalous pulmonary venous drainage

3

10%

6

20%

  1. HTK histidine-tryptophan-ketoglutarate, HHB hypothermic hyperkalemic blood, SD standard deviation, IQR interquartile range; *Student t test; **Chi-square test. P value < 0.05 was considered significant